Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 871

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 871
---
 of Stock Options The fair value of stock options granted for employee and non-employeeawards was estimated at the grant date using the Black-Scholes option pricing model based on the following assumptions:

|                         |     | Nine Months Ended September 30, |     |                 |
|                         |     |                            2024 |     |            2023 |
| Expected volatility     |     |                 121.8% - 124.9% |     | 111.1% - 113.1% |
| Expected term (years)   |     |                             1.0 |     |     5.35 - 6.08 |
| Risk-free interest rate |     |                   4.19% - 5.07% |     |     3.4% - 4.4% |
| Expected dividend yield |     |                              0% |     |              0% |

Restricted Stock The Company has granted restricted stock units (“RSUs”) under its equity incentive plans with both service-based and performance-based vesting conditions. As of September 30, 2024, the Company’s outstanding RSUs are time-based and have a grant date fair value of $63,000. F-138

The following table summarizes the Company’s restricted stock activity consisting of RSUs:

|                                                   |     | Number of  
 Restricted 
 Stock      
 (RSUs)     |        |   |     | Weighted-     
 Average Grant 
 Date Fair     
 Value Per     
 Share         |       |
|:--------------------------------------------------|:----|:-----------|-------:|:--|:----|:--------------|------:|
| Outstanding and unvested as of December 31, 2023  |     |            |  7,516 |   |     | $             | 27.14 |
| Exercised/Released                                |     |            | (4,191 | ) |     | $             | 27.20 |
| Cancelled/Forfeited                               |     |            | (1,032 | ) |     | $             | 26.16 |
| Outstanding and unvested as of September 30, 2024 |     |            |  2,293 |   |     | $             | 27.47 |

Stock-Based Compensation The following table summarizes total stock-based compensation included in the Company’s consolidated statements of operations:

|